我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 学术钥匙
  • 安全点亮
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Autism spectrum disorder and the promise of Artificial Intelligence

Jennifer Shannon, Carmela Salomon, Tobin Chettiath, Halim Abbas, Sharief Taraman

Since the U.S. Centers for Disease Control and Prevention began tracking the prevalence of autism spectrum disorder (ASD) over twenty years ago, rates have tripled, with an estimated one in 44 children now receiving a diagnosis [1]. Early ASD diagnosis and intervention during the critical neurodevelopmental window is recommended to enhance long-term outcomes [2-4]; yet many families experience diagnostic delays and challenges accessing services. Diagnostic barriers include long waits for specialist assessment, lengthy and fragmented evaluation processes, and limited primary care diagnostic capacity. Race, ethnicity, gender, geography, and socioeconomic status contribute to further delays for some populations [5-8]. Even after an ASD diagnosis is received, health services may struggle to fund and deliver targeted and timely interventions to the rapidly growing number of children requiring treatment. Data driven approaches to scale, streamline and enhance the quality of diagnostic and therapeutic ASD care available to families are urgently required. This narrative literature review considers the practice change potential of one such approach: Artificial Intelligence (AI) applied to the field of ASD. After providing a brief overview of AI in healthcare, we review a number of ASD specific AI-based approaches and consider their potential to augment current ASD diagnostic or treatment pathways. Key challenges associated with integrating AIbased technologies into clinical practice are also considered.